Long-term course of L-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency.

Schiller, A; Wevers, R A; Steenbergen, G C H; Blau, N; Jung, H H

Schiller, A; Wevers, R A; Steenbergen, G C H; Blau, N; Jung, H H.

Affiliation

Schiller A; Department of Neurology, University Hospital Zürich, Zürich, Switzerland.

Neurology ; 63(8): 1524-6, 2004 Oct 26.

Article in En | MEDLINE | ID: mdl-15505183

Subject(s)

Brain Chemistry/genetics; Catecholamines/deficiency; Dystonia/enzymology; Levodopa/therapeutic use; Point Mutation/genetics; Tyrosine 3-Monooxygenase/deficiency; Adult; Age of Onset; Brain/enzymology; Brain/pathology; Brain/physiopathology; Catecholamines/biosynthesis; DNA Mutational Analysis; Disease Progression; Dopamine Agents/adverse effects; Dopamine Agents/therapeutic use; Dystonia/drug therapy; Dystonia/genetics; Heterozygote; Humans; Levodopa/adverse effects; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Panic Disorder/chemically induced; Siblings; Time; Tyrosine 3-Monooxygenase/genetics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tyrosine 3-Monooxygenase / Brain Chemistry / Catecholamines / Levodopa / Point Mutation / Dystonia Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Neurology Year: 2004 Document type: Article Affiliation country: Switzerland Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links